Contraceptive market, utilization patterns, and coverage in Colombia (2020-2025)

Area of Science:

• Public Health
• Reproductive Health
• Health Economics

Background:

• Contraceptive market dynamics significantly impact reproductive health access.
• Understanding disparities between insurance-covered and out-of-pocket contraceptive purchases is crucial for equitable healthcare.
• Colombia's pharmaceutical databases offer valuable insights into market behavior.

Purpose of the Study:

• To analyze contraceptive market dynamics in Colombia.
• To compare pricing, utilization, and coverage between insurance-covered and out-of-pocket groups.
• To identify barriers to equitable reproductive health access.

Main Methods:

• Retrospective analysis of national pharmaceutical databases (2020-2025).
• Examination of pricing, market values, utilization (DDDs/1000 women-years), and population coverage (CYP).
• Comparison between insurance-covered and out-of-pocket purchase groups.

Main Results:

• Out-of-pocket spending dominates the market (64-70%) for oral contraceptives and emergency contraception.
• Significant price disparities exist, with out-of-pocket emergency contraception up to 25 times higher.
• Insurance-covered groups, though reaching only 8-10% of the population, specialize in highly effective long-acting reversible methods.
• Total contraceptive utilization is heavily skewed towards out-of-pocket purchases (78-86%).

Conclusions:

• Colombia's contraceptive market exhibits segmentation and structural barriers beyond mere pricing.
• Policy interventions must enhance insurance-covered service delivery and reform the out-of-pocket sector for equitable access.
• Strengthening institutional capacity for long-acting reversible methods and ensuring commercial equity are vital for comprehensive contraceptive access.